P2B001
Pharma Two B
[]
this morning at , david l. kreitzman, m.d., shared results from a randomized controlled phase 3 trial showing p2b001 significantly reduced the risk of excessive daytime sleepiness in early #parkinsonsdisease. #aanam 
Pharma Two B is a clinical-stage pharmaceutical company striving to improve patients’ quality of life by developing innovative combination products.